title: [Thromboembolic risk].
authors.forename: M
authors.initials: M
authors.lastname: Campisi
authors.forename: R
authors.initials: R
authors.lastname: Stacca
authors.forename: A
authors.initials: A
authors.lastname: Tassi
authors.forename: G
authors.initials: G
authors.lastname: Laganà
authors.forename: P
authors.initials: P
authors.lastname: Piccinini
mesh_terms: D000368:Aged; D004087:Dihydroergotamine / Q000627:therapeutic use; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011089:Polydeoxyribonucleotides / Q000627:therapeutic use; D011183:Postoperative Complications / Q000209:etiology* / Q000517:prevention & control; D011655:Pulmonary Embolism / Q000209:etiology / Q000517:prevention & control; D012307:Risk Factors; D013923:Thromboembolism / Q000209:etiology* / Q000517:prevention & control; D013924:Thrombophlebitis / Q000209:etiology / Q000517:prevention & control
chemical_list: D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D011089:Polydeoxyribonucleotides; D004087:Dihydroergotamine; C036901:defibrotide; D006493:Heparin
vernacular_title: Rischio tromboembolico.